(0.80%) 5 277.51 points
(1.51%) 38 686 points
(-0.01%) 16 735 points
(-0.04%) $76.96
(4.21%) $2.70
(-0.17%) $2 341.90
(-0.21%) $30.38
(0.47%) $1 046.90
(0.00%) $0.921
(0.00%) $10.49
(-0.05%) $0.785
(-0.29%) $90.17
@ $11.31
Issued: 14 Feb 2024 @ 14:07
Return: -20.51%
Previous signal: Feb 13 - 13:45
Previous signal:
Return: -1.65 %
Live Chart Being Loaded With Signals
ORIC Pharmaceuticals, Inc., a clinical-stage biopharmaceutical company, discovers and develops therapies for treatment of cancers in the United States...
Stats | |
---|---|
Today's Volume | 867 351 |
Average Volume | 524 230 |
Market Cap | 606.13M |
EPS | $0 ( 2024-05-13 ) |
Next earnings date | ( $-0.440 ) 2024-06-12 |
Last Dividend | $0 ( N/A ) |
Next Dividend | $0 ( N/A ) |
P/E | -4.99 |
ATR14 | $0.0130 (0.14%) |
Date | Person | Action | Amount | type |
---|---|---|---|---|
2024-03-06 | Chacko Jacob | Sell | 40 000 | Common Stock |
2024-02-06 | Chacko Jacob | Sell | 13 958 | Common Stock |
2024-02-07 | Chacko Jacob | Sell | 26 042 | Common Stock |
2024-01-02 | Multani Pratik S | Buy | 180 000 | Stock Option (right to buy) |
2024-01-02 | Multani Pratik S | Buy | 30 000 | Restricted Stock Unit |
INSIDER POWER |
---|
58.25 |
Last 99 transactions |
Buy: 6 373 472 | Sell: 3 807 004 |
Volume Correlation
Oric Pharmaceuticals Inc Correlation
10 Most Positive Correlations | |
---|---|
SPOK | 0.881 |
NTRSO | 0.855 |
PBBK | 0.849 |
SVRE | 0.848 |
OPTN | 0.848 |
HCKT | 0.846 |
ACHL | 0.844 |
CSX | 0.841 |
AMD | 0.841 |
ROST | 0.836 |
Did You Know?
Correlation is a statistical measure that describes the relationship between two variables. It ranges from -1 to 1, where -1 indicates a perfect negative correlation (as one variable increases, the other decreases), 1 indicates a perfect positive correlation (as one variable increases, the other increases), and 0 indicates no correlation (there is no relationship between the variables).
Correlation can be used to analyze the relationship between any two variables, not just stocks. It's commonly used in fields such as finance, economics, psychology, and more.
Oric Pharmaceuticals Inc Correlation - Currency/Commodity
Oric Pharmaceuticals Inc Financials
Annual | 2023 |
Revenue: | $0 |
Gross Profit: | $-1.03M (0.00 %) |
EPS: | $-1.960 |
FY | 2023 |
Revenue: | $0 |
Gross Profit: | $-1.03M (0.00 %) |
EPS: | $-1.960 |
FY | 2022 |
Revenue: | $0 |
Gross Profit: | $-966 000 (0.00 %) |
EPS: | $-2.31 |
FY | 2021 |
Revenue: | $0.00 |
Gross Profit: | $0.00 (0.00 %) |
EPS: | $-2.07 |
Financial Reports:
No articles found.
Contract Name | Last Trade Date (EDT) | Strike | Last Price | Bid | Ask | Change | % Change | Volume | Open Interest | Implied Volatility | Strike Date |
---|---|---|---|---|---|---|---|---|---|---|---|
No data available |
Contract Name | Last Trade Date (EDT) | Strike | Last Price | Bid | Ask | Change | % Change | Volume | Open Interest | Implied Volatility | Strike Date |
---|---|---|---|---|---|---|---|---|---|---|---|
No data available |
Oric Pharmaceuticals Inc
ORIC Pharmaceuticals, Inc., a clinical-stage biopharmaceutical company, discovers and develops therapies for treatment of cancers in the United States. Its clinical stage product candidates include ORIC-533, an orally bioavailable small molecule inhibitor of CD73 being developed for resistance to chemotherapy- and immunotherapy-based treatment regimens; ORIC-944, an allosteric inhibitor of the polycomb repressive complex 2 for prostate cancer; and ORIC-114, a brain penetrant orally bioavailable irreversible inhibitor designed to selectively target epidermal growth factor receptor and human epidermal growth factor receptor 2 with high potency towards exon 20 insertion mutations. The company is also developing multiple discovery stage precision medicines targeting other cancer resistance mechanisms. It has a license and collaboration agreement with Voronoi Inc.; and a license agreement with Mirati Therapeutics, Inc. The company was incorporated in 2014 and is headquartered in South San Francisco, California.
About Live Signals
The live signals presented on this page help determine when to BUY or SELL NA. The signals have upwards of a 1-minute delay; like all market signals, there is a chance for error or mistakes.
The live trading signals are not definite, and getagraph.com hold no responsibility for any action taken upon these signals, as described in the Terms of Use. The signals are based on a wide range of technical analysis indicators